Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

422
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
422
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

47.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.0K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.8K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.8K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

360
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
360
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

182
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
182
Standard Precaution01:26

Standard Precaution

2.2K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GIDISdb: a gene expression database for exploring human immune responses in infectious diseases.

Database : the journal of biological databases and curation·2026
Same author

From silenced shock to strategic resilience: a longitudinal qualitative study of nurse residents' trajectory in coping with patient verbal abuse.

Frontiers in psychology·2026
Same author

In Situ Oxygen Shuttling within a Bilayer Electrified Membrane Enables Aeration-Free Electro-Fenton Water Purification.

ACS nano·2026
Same author

Evaluation of a Digital Intervention for Monitoring and Improving Medication Adherence Among Real-World e-Consumers of HIV Preexposure Prophylaxis in China: Protocol for a Randomized Controlled Trial.

JMIR research protocols·2026
Same author

Resilient interpersonal pathways from loneliness to suicidal ideation among Chinese transgender women during global health crises.

General psychiatry·2026
Same author

Preventing complications in cardiac pacemaker therapy: a lifecycle-based risk management framework.

Frontiers in cardiovascular medicine·2026

Related Experiment Video

Updated: Sep 18, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.5K

Biomedical Interventions for HIV Prevention and Control: Beyond Vaccination.

Yu Liao1,2, Ziyu Wen1,2, Minjuan Shi1,2

  • 1School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.

Viruses
|June 27, 2025
PubMed
Summary
This summary is machine-generated.

Innovative biomedical interventions are crucial for controlling the human immunodeficiency virus (HIV) epidemic. This review explores challenges and advances in developing new HIV prevention and treatment strategies beyond vaccines.

Keywords:
2030 goalAIDS epidemicHIVbiomedical interventionsprevention

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.7K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

31.8K

Related Experiment Videos

Last Updated: Sep 18, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.5K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.7K
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

31.8K

Area of Science:

  • Infectious Diseases
  • Vaccinology
  • Public Health

Background:

  • The global human immunodeficiency virus (HIV) epidemic persists due to the lack of a cure or broadly effective vaccine.
  • Biomedical interventions are key to controlling HIV transmission and acquisition.
  • An effective HIV vaccine remains a critical, yet unavailable, tool.

Purpose of the Study:

  • To discuss challenges in innovating biomedical interventions against HIV.
  • To summarize the current landscape and recent advances in HIV biomedical interventions.
  • To identify novel strategies for HIV prevention and control, aiding the 2030 AIDS epidemic goals.

Main Methods:

  • Literature review and synthesis of existing research on HIV biomedical interventions.
  • Analysis of technical hurdles in HIV vaccine and drug development.
  • Exploration of alternative and innovative approaches for HIV prevention.

Main Results:

  • Despite challenges, various innovative biomedical interventions are emerging for HIV prevention and control.
  • Advances focus on intercepting HIV acquisition and transmission routes.
  • The development pipeline includes strategies beyond traditional vaccination.

Conclusions:

  • Overcoming innovation challenges is vital for advancing HIV biomedical interventions.
  • A multifaceted approach combining existing and novel strategies is needed.
  • Continued research into out-of-the-box solutions is essential to end the AIDS epidemic by 2030.